Pellicori P, Ferreira JP, Mariottoni B, Brunner-La Rocca HP, et al. Effects of spironolactone on serum markers of fibrosis in people at high risk of
developing heart failure: rationale, design and baseline characteristics of a
proof-of-concept, randomised, precision-medicine, prevention trial. The Heart
OMics in AGing Eur J Heart Fail 2020 Jan 16. doi: 10.1002/ejhf.1716.
PMID: 31950604